LifeStance Health Group, Inc.

LFST

LifeStance Health Group, Inc.

LFST

Insider Sentiment (TTM):

Last Purchase:2025-08-11Last Sale:2026-06-26Shares Purchased (TTM):20,000Shares Sold (TTM):81,690,223

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:367,636,727Shares Outstanding:387,264,000Institutional Ownership Pct.:94.93%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Health Services

PRVA WGS USPH INNV PNTG TALK

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Cash And Cash Equivalents At Carrying Value	195	249	204	189	134	155	103	87	49	79	43	80
Accounts Receivable Net Current	123	96	121	129	140	132	158	167	176	125	150	122
Assets Current
Assets Current	356	416	360	359	305	313	287	278	244	226	264	238
Prepaid Expense And Other Assets Current	38	72	35	40	30	26	26	24	19	22	72	36
Property Plant And Equipment Net	161	162	163	161	164	166	170	176	182	188	190	193
Operating Lease Right Of Use Asset	152	150	146	143	148	148	155	160	166	171	181	191
Assets Noncurrent
Assets Noncurrent	1,790	1,788	1,789	1,788	1,800	1,806	1,821	1,842	1,862	1,884	1,911	1,933
Intangible Assets Net Excluding Goodwill	175	178	181	184	187	191	195	200	209	221	234	244
Goodwill	1,297	1,293	1,293	1,293	1,293	1,293	1,293	1,293	1,293	1,293	1,293	1,294
Other Assets Noncurrent	5	5	6	7	8	8	7	12	12	11	13	11
Assets	2,146	2,204	2,149	2,147	2,105	2,118	2,108	2,119	2,106	2,110	2,175	2,171
Liabilities And Stockhold…
Accounts Payable Current	4	6	12	8	7	7	7	10	12	7	10	8
Employee Related Liabilities Current	117	143	114	129	100	117	112	123	100	102	84	81
Other Accrued Liabilities Current	52	42	42	47	43	47	43	38	37	35	91	34
Liabilities Current
Liabilities Current	240	252	229	242	207	229	218	228	207	203	241	181
Operating Lease Liability Current	47	46	47	47	47	49	49	49	50	46	44	43
Business Combination Contingent Consideration Liab…	-	-	-	-	-	0	3	4	4	8	9	11
Other Liabilities Current	18	15	13	11	10	8	4	4	4	4	3	3
Long Term Debt Noncurrent	262	266	269	273	276	280	279	279	280	280	248	249
Operating Lease Liability Noncurrent	149	149	144	143	149	149	159	166	173	181	192	206
Liabilities Noncurrent
Deferred Income Tax Liabilities Net	16	16	14	14	14	14	15	16	16	16	38	38
Liabilities Noncurrent	429	431	428	431	440	443	453	462	470	478	479	495
Other Liabilities Noncurrent	1	0	0	0	0	0	0	1	1	1	1	3
Liabilities	668	683	656	673	648	672	671	689	677	681	720	676
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	4	4	4	4	4	4	4	4	4	4	4	4
Additional Paid In Capital Common Stock	2,268	2,326	2,309	2,291	2,270	2,260	2,244	2,229	2,204	2,184	2,163	2,141
Stockholders Equity
Stockholders Equity	1,477	1,521	1,493	1,474	1,457	1,446	1,437	1,430	1,429	1,429	1,455	1,495
Accumulated Other Comprehensive Income Loss Net Of…	-	0	0	0	1	1	1	3	3	2	4	4
Retained Earnings Accumulated Deficit	-794	-809	-820	-821	-818	-818	-811	-805	-782	-761	-716	-654
Liabilities And Stockholders Equity	2,146	2,204	2,149	2,147	2,105	2,118	2,108	2,119	2,106	2,110	2,175	2,171
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	800
Common Stock Shares Issued	388	388	389	389	389	383	383	383	382	379	379	378
Shares Outstanding	388	388	389	389	389	383	383	383	382	379	379	378

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-12.88%	16.16%	-	-	-	-	-	-	-	-	-	-
2025	7.80%	-6.53%	-24.86%	41.97%	40.41%	34.72%	4.00%	14.08%	17.44%	-13.63%	-7.02%	3.24%
2024	-21.77%	-31.04%	-21.63%	6.41%	17.03%	15.51%	-2.08%	-2.47%	3.78%	-11.50%	-13.44%	-24.55%
2023	2.42%	10.53%	10.53%	-1.99%	-14.76%	-30.15%	12.54%	34.54%	10.48%	-31.92%	-34.44%	-15.15%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.48	1.65	1.58	1.48	1.47	1.37	1.32	1.22	1.18	1.11	1.10	1.32
Quick Ratio	1.33	1.37	1.42	1.31	1.32	1.25	1.20	1.12	1.09	1.01	0.80	1.11
Working Capital	116.18M	164.24M	131.82M	116.56M	97.25M	83.62M	69.51M	50.09M	36.65M	22.86M	23.38M	57.03M
Leverage & Debt
Debt to Equity	0.45	0.45	0.44	0.46	0.44	0.46	0.47	0.48	0.47	0.48	0.49	0.45
Interest Coverage TTM	4.32	2.07	0.39	-0.01	-0.56	-1.19	-2.86	-6.13	-7.80	-8.91	-9.73	-8.55
Debt Ratio	0.31	0.31	0.31	0.31	0.31	0.32	0.32	0.33	0.32	0.32	0.33	0.31
Efficiency & Turnover
Asset Turnover TTM	0.70	0.66	0.64	0.62	0.61	0.59	0.56	0.54	0.52	0.49	0.48	0.46
Days Sales Outstanding TTM	32.14	29.15	37.26	41.13	44.98	37.52	46.59	45.62	48.67	39.12	47.79	42.16
Receivables Turnover TTM	11.35	12.52	9.80	8.87	8.12	9.73	7.83	8.00	7.50	9.33	7.64	8.66
Per Share Metrics
Diluted EPS TTM	0.06	0.02	-0.02	-0.04	-0.09	-0.15	-0.25	-0.40	-0.46	-0.51	-0.50	-0.45
Free Cash Flow Per Share TTM	0.37	0.29	0.31	0.31	0.27	0.23	0.09	-0.05	-0.18	-0.16	-0.10	-0.03
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	101.97%	102.00%	102.01%	102.08%	102.04%
Operating Profit Margin TTM	3.00%	1.70%	0.52%	-0.02%	-1.03%	-2.53%	-5.38%	-12.05%	-15.57%	-17.92%	-20.20%	-17.45%
Net Profit Margin TTM	1.55%	0.68%	-0.67%	-1.23%	-2.78%	-4.59%	-7.90%	-13.05%	-15.69%	-17.64%	-18.71%	-17.12%
Growth Metrics
Net Revenue Growth (1Y)	16.46%	13.85%	13.39%	13.86%	16.31%	18.50%	20.08%	20.56%	21.39%	22.82%	4.27%	4.30%
Net Income Growth (1Y)	-165.09%	-116.82%	-90.43%	-89.30%	-79.41%	-69.16%	-49.30%	-8.11%	-7.66%	-13.59%	-41.69%	-59.45%
EPS Growth (1Y)	-164.42%	-116.52%	-90.60%	-89.50%	-79.79%	-70.11%	-50.35%	-12.05%	-11.45%	-16.46%	-44.04%	-60.50%
Valuation Metrics
P/E TTM	106.34	281.23	-233.44	-123.79	-71.63	-48.64	-27.94	-12.34	-13.41	-15.45	-13.61	-20.19
P/B TTM	1.67	1.79	1.43	1.36	1.75	1.93	1.85	1.30	1.62	2.01	1.76	2.22
P/S TTM	1.65	1.91	1.56	1.52	1.99	2.23	2.21	1.61	2.10	2.73	2.55	3.46
Market Cap	2.47B	2.72B	2.13B	2.00B	2.55B	2.79B	2.66B	1.86B	2.32B	2.88B	2.56B	3.32B
Enterprise Value	2.53B	2.73B	2.19B	2.08B	2.69B	2.92B	2.84B	2.06B	2.55B	3.08B	2.76B	3.48B
Calculated Values
Free Cash Flow TTM	142.63M	110.03M	119.39M	120.07M	102.38M	85.69M	35.06M	-17.76M	-68.73M	-57.40M	-37.25M	-11.47M
Net Debt	67.66M	17.29M	65.49M	83.93M	141.99M	125.22M	176.44M	192.49M	230.42M	201.46M	205.77M	169.11M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-26Sale

Owner: Bessler, Robert

Title: -

Shares: 894,337

Price/Share: $10.13

Value: $9,059,633.81

Shares Owned: 539,763

Relationship: Director

Ownership: Indirect

2026-05-12Sale

Owner: Tpg, Gp A, Llc, Coulter J…

Title: -

Shares: 28,281,943

Price/Share: $8.02

Value: $226,821,182.86

Shares Owned: 111,744,614

Relationship: TenPercentOwner

Ownership: Indirect

2026-05-12Sale

Owner: Bessler, Robert

Title: -

Shares: 575,034

Price/Share: $8.02

Value: $4,611,772.68

Shares Owned: 986,931

Relationship: Director

Ownership: Indirect

2026-05-12Sale

Owner: Shuey, Eric

Title: -

Shares: 243,362

Price/Share: $8.02

Value: $1,951,763.24

Shares Owned: 867,562

Relationship: Director

Ownership: Indirect

2026-05-12Sale

Owner: Black, Darren M.

Title: -

Shares: 5,899,661

Price/Share: $8.02

Value: $47,315,281.22

Shares Owned: 23,310,115

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-26	Bessler, Robert	Director	-	Indirect	Sale	894,337	10.13	$9,059,633.81	539,763	4
2026-05-12	Tpg, Gp A, Llc, Coulter J…	TenPercentOwner	-	Indirect	Sale	28,281,943	8.02	$226,821,182.86	111,744,614	4
2026-05-12	Bessler, Robert	Director	-	Indirect	Sale	575,034	8.02	$4,611,772.68	986,931	4
2026-05-12	Shuey, Eric	Director	-	Indirect	Sale	243,362	8.02	$1,951,763.24	867,562	4
2026-05-12	Black, Darren M.	Director	-	Indirect	Sale	5,899,661	8.02	$47,315,281.22	23,310,115	4
2026-05-07	Bessler, Robert	Director	-	Indirect	Sale	75,000	8.55	$641,250.00	1,236,948	4
2026-04-24	Bessler, Robert	Director	-	Indirect	Sale	62,147	7.05	$438,136.35	1,274,448	4
2026-04-21	Bessler, Robert	Director	-	Indirect	Sale	5,101	7.01	$35,758.01	1,309,397	4
2026-03-02	Tpg, Gp A, Llc, Coulter J…	TenPercentOwner	-	Indirect	Sale	20,685,061	7.01	$145,002,277.61	140,026,557	4
2026-03-02	Black, Darren M.	Director	-	Indirect	Sale	4,314,939	7.01	$30,247,722.39	29,209,776	4
2025-12-19	Bessler, Robert	Director	-	Indirect	Sale	119,942	7.04	$844,391.68	1,318,983	4
2025-12-18	Bessler, Robert	Director	-	Indirect	Sale	6,442	7.00	$45,094.00	1,378,954	4
2025-12-17	Varanakis, Ann	Officer	Chief People Officer	Direct	Sale	50,000	6.90	$345,000.00	315,610	4
2025-12-15	Bessler, Robert	Director	-	Indirect	Sale	12,371	7.00	$86,597.00	1,375,989	4
2025-11-21	Miller, Lisa K	Officer	See Remarks	Direct	Sale	57,240	6.43	$368,053.20	261,292	4
2025-08-18	Summit, Partners L P, Sum…	Other	-	Direct	Sale	8,407,643	5.07	$42,626,750.01	33,524,715	4
2025-08-18	Black, Darren M.	Director,TenPercentOwner	-	Indirect	Sale	8,407,643	5.07	$42,626,750.01	33,524,715	4
2025-08-18	Silversmith, Capital Part…	Other	-	Indirect	Sale	3,592,357	5.07	$18,213,249.99	14,324,197	4
2025-08-11	Burdick, Kenneth A	Director	-	Direct	Purchase	20,000	4.44	$88,800.00	3,436,571	4
2025-06-16	Ramtekkar, Ujjwal	Officer	Chief Medical Officer	Direct	Sale	9,519	5.17	$49,213.23	103,916	4
2025-06-05	Ramtekkar, Ujjwal	Officer	Chief Medical Officer	Direct	Sale	16,000	5.94	$95,040.00	113,435	4
2025-04-09	Bessler, Robert	Director	-	Indirect	Sale	4,900	7.01	$34,349.00	1,421,990	4
2025-03-17	Miller, Lisa K	Officer	See Remarks	Direct	Sale	18,845	6.90	$130,030.50	339,810	4
2025-03-10	Pantaleoni, Pablo	Officer	Chief Digital Officer	Indirect	Sale	15,605	7.64	$119,222.20	522,580	4
2024-11-27	Bessler, Robert	Director	-	Indirect	Sale	75,000	7.54	$565,500.00	1,424,447	4
2024-11-13	Miller, Lisa K	Officer	See Remarks	Direct	Sale	10,540	7.45	$78,523.00	288,994	4
2024-08-23	Varanakis, Ann	Officer	Chief People Officer	Direct	Sale	5,269	6.28	$33,089.32	263,007	4
2024-06-14	Qureshi, Danish J.	Officer	See Remarks	Indirect	Sale	150,000	5.21	$781,500.00	439,002	4
2024-06-12	Pardo, Ryan	Officer	See Remarks	Direct	Sale	61,508	5.40	$332,143.20	746,439	4
2024-06-11	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	85,093	5.53	$470,564.29	4,650,571	4
2024-06-10	Qureshi, Danish J.	Officer	See Remarks	Direct	Sale	83,109	5.25	$436,322.25	4,827,941	4
2024-05-24	Silversmith, Capital Part…	Other	-	Indirect	Sale	1,624,638	5.89	$9,569,117.82	17,916,554	4
2024-05-24	Black, Darren M.	Director,TenPercentOwner	-	Indirect	Sale	3,802,345	5.89	$22,395,812.05	41,932,358	4
2024-05-24	Summit, Investors Ge Ix/V…	TenPercentOwner	-	Direct	Sale	3,802,345	5.89	$22,395,812.05	41,932,358	4
2024-05-24	Crisan, Jeffrey	Director,Other	-	Indirect	Sale	1,624,638	5.89	$9,569,117.82	17,916,554	4
2024-05-24	Winkelried, Jon, Bonderma…	TenPercentOwner	-	Indirect	Sale	14,573,017	5.89	$85,835,070.13	160,711,618	4
2024-05-24	Summit, Partners Ge Ix, L…	Other	-	Indirect	Sale	3,802,345	5.89	$22,395,812.05	41,932,358	4
2024-05-13	Cipollone, Paula	Officer	See Remarks	Direct	Sale	48,278	7.22	$348,567.16	239,915	4
2024-04-01	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	9,688	5.93	$57,449.84	4,735,664	4
2024-04-01	Pardo, Ryan	Officer	See Remarks	Direct	Sale	9,830	5.93	$58,291.90	807,947	4
2024-04-01	Qureshi, Danish J.	Officer	See Remarks	Direct	Sale	12,965	5.93	$76,882.45	4,911,050	4
2024-04-01	Pantaleoni, Pablo	Officer	Chief Digital Officer	Direct	Sale	10,116	5.93	$59,987.88	1,299,927	4
2024-03-15	Burdick, Kenneth A	Director,Officer	Chief Executive Officer	Direct	Sale	214,605	6.28	$1,347,719.40	2,934,372	4
2024-03-14	Pardo, Ryan	Officer	See Remarks	Direct	Sale	39,384	6.33	$249,300.72	817,777	4
2024-03-14	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	44,540	6.33	$281,938.20	4,745,352	4
2024-03-13	Qureshi, Danish J.	Officer	See Remarks	Direct	Sale	153,943	6.32	$972,919.76	4,924,015	4
2024-03-12	Pantaleoni, Pablo	Officer	Chief Digital Officer	Direct	Sale	43,304	6.76	$292,735.04	1,310,043	4
2024-03-11	Cipollone, Paula	Officer	See Remarks	Direct	Sale	13,996	6.93	$96,992.28	293,562	4
2024-03-11	Bourdon, David	Officer	Chief Financial Officer	Direct	Sale	58,826	6.93	$407,664.18	433,856	4
2024-03-11	Varanakis, Ann	Officer	Chief People Officer	Direct	Sale	15,434	6.93	$106,957.62	268,276	4
2024-03-01	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	115,136	8.02	$923,390.72	4,575,480	4
2024-01-03	Cipollone, Paula	Officer	See Remarks	Direct	Sale	3,369	7.45	$25,099.05	290,193	4
2023-12-01	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	113,334	6.54	$741,204.36	4,690,616	4
2023-11-07	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	32,056	6.12	$196,182.72	4,803,950	4
2023-11-03	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	80,977	6.13	$496,389.01	4,836,306	4
2023-10-02	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	113,333	6.61	$749,131.13	4,917,283	4
2023-09-01	Gouk, Warren	Officer	Chief Administrative Officer	Direct	Sale	38,058	8.25	$313,978.50	5,818,204	4
2023-08-24	Varanakis, Ann	Officer	Chief People Officer	Direct	Sale	5,661	7.60	$43,023.60	168,441	4
2023-07-06	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	135,400	8.67	$1,173,918.00	5,030,616	4
2023-07-05	Mullins, Kevin Michael	Officer	Chief Development Officer	Direct	Sale	150,000	8.72	$1,308,000.00	5,166,016	4
2023-06-28	Patel-Dunn, Anisha	Officer	Chief Medical Officer	Direct	Sale	2,602	9.24	$24,042.48	277,055	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

94.93%

Inst. Shares: 367,636,727

Shares Outstanding: 387,264,000

2025-12-31

96.50%

Inst. Shares: 372,513,673

Shares Outstanding: 386,016,000

2025-09-30

90.91%

Inst. Shares: 351,774,069

Shares Outstanding: 386,963,000

2025-06-30

88.45%

Inst. Shares: 342,079,451

Shares Outstanding: 386,733,000

2025-03-31

88.38%

Inst. Shares: 338,740,569

Shares Outstanding: 383,272,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	367,636,727	387,264,000	94.93%
2025-12-31	372,513,673	386,016,000	96.50%
2025-09-30	351,774,069	386,963,000	90.91%
2025-06-30	342,079,451	386,733,000	88.45%
2025-03-31	338,740,569	383,272,000	88.38%
2024-12-31	334,400,533	379,147,000	88.20%
2024-09-30	322,712,378	380,359,000	84.84%
2024-06-30	319,304,017	379,427,000	84.15%
2024-03-31	320,016,415	376,331,000	85.04%
2023-12-31	308,424,036	367,457,000	83.93%
2023-09-30	297,213,214	372,476,000	79.79%
2023-06-30	289,562,405	363,161,000	79.73%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

LifeStance Health Group, Inc. (LFST) — SEC Financial Statements & Analysis

LifeStance Health Group, Inc. (LFST) is a services-health services company, incorporated in DE. LifeStance Health Group, Inc. trades on Nasdaq as: LFST. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), LifeStance Health Group, Inc. reported a 16.46% year-over-year revenue growth, a Gross Profit Margin of 101.97% (TTM), a Debt-to-Equity ratio of 0.45x, a Price-to-Sales (P/S) ratio of 1.65x (TTM), a Price-to-Book (P/B) ratio of 1.67 (TTM), at a market cap of $2.47B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 16.46%
Gross Profit Margin TTM: 101.97%
Debt To Equity: 0.45x
P/S TTM: 1.65x
P/B TTM: 1.67
Market Cap: $2.47B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LifeStance Health Group, Inc. in?

LifeStance Health Group, Inc. (LFST) operates in the Services-Health Services industry.

What is LFST's market cap?

LifeStance Health Group, Inc. (LFST) has a market capitalization of $2.47B as of 2026-03-31.

What is LFST's P/E ratio?

LifeStance Health Group, Inc. (LFST)'s trailing twelve month P/E ratio is 106.34x as of 2026-03-31.

What exchange does LFST trade on?

LifeStance Health Group, Inc. (LFST) trades on the Nasdaq.

Where is LifeStance Health Group, Inc. incorporated?

LifeStance Health Group, Inc. is incorporated in DE.

LifeStance Health Group, Inc. (LFST) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.